SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-24-075304
Filing Date
2024-03-22
Accepted
2024-03-22 16:28:32
Documents
1
Effectiveness Date
2024-03-22

Document Format Files

Seq Description Document Type Size
1 POSASR d808408dposasr.htm POSASR 20200
  Complete submission text file 0001193125-24-075304.txt   21452
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-270796 | Film No.: 24775644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)